These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Preventing cervical cancer by vaccinating against HPV. Campbell K Nurs Times; 2005 Nov 15-21; 101(46):21-2. PubMed ID: 16315796 [TBL] [Abstract][Full Text] [Related]
27. The potential of human papillomavirus vaccines. Steinbrook R N Engl J Med; 2006 Mar; 354(11):1109-12. PubMed ID: 16540608 [No Abstract] [Full Text] [Related]
29. Global aspirations for HPV vaccination. Senior K Lancet Infect Dis; 2008 Mar; 8(3):150. PubMed ID: 18363221 [No Abstract] [Full Text] [Related]
30. Routine vaccination against human papillomavirus. Lancet Infect Dis; 2008 Mar; 8(3):141. PubMed ID: 18291330 [No Abstract] [Full Text] [Related]
31. Comparison of papillomavirus and immunodeficiency virus evolutionary patterns in the context of a papillomavirus vaccine. Halpern AL J Clin Virol; 2000 Oct; 19(1-2):43-56. PubMed ID: 11091147 [TBL] [Abstract][Full Text] [Related]
32. Are we closer to the prevention of HPV-related diseases? Harper DM J Fam Pract; 2005 Jul; Suppl HPV Prevention():S10-6; quiz S23. PubMed ID: 16093008 [No Abstract] [Full Text] [Related]
34. Neutralization of human papillomavirus type 11 (HPV-11) by serum from women vaccinated with yeast-derived HPV-11 L1 virus-like particles: correlation with competitive radioimmunoassay titer. Brown DR; Bryan JT; Schroeder JM; Robinson TS; Fife KH; Wheeler CM; Barr E; Smith PR; Chiacchierini L; DiCello A; Jansen KU J Infect Dis; 2001 Nov; 184(9):1183-6. PubMed ID: 11598842 [TBL] [Abstract][Full Text] [Related]
35. Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes. Roden RB; Yutzy WH; Fallon R; Inglis S; Lowy DR; Schiller JT Virology; 2000 May; 270(2):254-7. PubMed ID: 10792983 [TBL] [Abstract][Full Text] [Related]
36. [Can human papillomavirus testing and vaccination prevent cervical cancer?]. Lie AK; Bjørge T; Helland A; Hagen B; Skjeldestad FE; Hagmar B; Thoresen S Tidsskr Nor Laegeforen; 2001 Oct; 121(25):2947-51. PubMed ID: 11715778 [TBL] [Abstract][Full Text] [Related]
37. The 18th International Papillomavirus Conference. Bonnez W Antivir Ther; 2000 Dec; 5(4):279-83. PubMed ID: 11142623 [No Abstract] [Full Text] [Related]
38. [Perspectives for the development of vaccines and immunotherapy against cervico-uterine cancer]. Guzmán-Rojas L; Alcocer-González JM; Madrid-Marina V Salud Publica Mex; 1998; 40(1):38-46. PubMed ID: 9567657 [TBL] [Abstract][Full Text] [Related]
39. FDA approves Gardasil 9 for more types of HPV. Printz C Cancer; 2015 Apr; 121(8):1156-7. PubMed ID: 25855331 [No Abstract] [Full Text] [Related]
40. Eligibility and willingness of young Icelandic women to participate in a HPV vaccination trial. Gudmundsdóttir T; Tryggvadóttir L; Allende M; Mast TC; Briem H; Sigurdsson K Acta Obstet Gynecol Scand; 2003 Apr; 82(4):345-50. PubMed ID: 12716319 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]